United Therapeutics Chairperson, CEO Martine A. Rothblatt disposes of USD 4.3 million in common shares

• United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $117.76 on Oct. 9, 2026.
• Family trust sold 9,099 shares at prices from $531.92 to $550.7197 on the same day.
• Trust’s common stock stake ended at 324,443 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000161), on October 13, 2026, and is solely responsible for the information contained therein.